US0905722072
US0905722072
Bio-Rad Laboratories, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 2.583.200.000 | 2.566.500.000 | 0.7% |
| Cost of Revenue | 1.243.300.000 | 1.187.600.000 | 4.7% |
| Gross Profit | 1.339.900.000 | 1.378.900.000 | 2.8% |
| 1.121.300.000 | 1.109.900.000 | 1.0% | |
| Operating Income | 218.600.000 | 269.000.000 | 18.7% |
| Pretax Income | 995.500.000 | -2.342.500.000 | 142.5% |
| Net Income Common Stockholders | 759.900.000 | -1.844.200.000 | 141.2% |
| -- | -- | -- | |
| -- | -- | -- |